C07J 3/005
The carbon atom being part of a carboxylic function
Official title: {the carbon atom being part of a carboxylic function}
C07J3/005 (The carbon atom being part of a carboxylic function) appears on 121 US grants and 82 published applications in this corpus.
Search patents in C07J- Granted patents
- 121
- Published applications
- 82
- Assignees
- 54
- Inventors
- 222
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 7 | 0 |
| 1981 | 6 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 3 | 3 |
| 2004 | 1 | 6 |
| 2005 | 1 | 8 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 6 |
| 2009 | 2 | 3 |
| 2010 | 3 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 3 |
| 2014 | 2 | 3 |
| 2015 | 1 | 3 |
| 2016 | 4 | 9 |
| 2017 | 7 | 3 |
| 2018 | 1 | 3 |
| 2019 | 3 | 3 |
| 2020 | 3 | 4 |
| 2021 | 2 | 6 |
| 2022 | 3 | 3 |
| 2023 | 5 | 5 |
| 2024 | 1 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Compositions and methods for treating CNS disorders20 Aug 2024US 12,065,463 B2Sage Therapeutics, Inc.
- Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof14 Nov 2023US 11,814,408 B2Nicox Ophthalmics, Inc.
- Methods to induce targeted protein degradation through bifunctional molecules21 Feb 2023US 11,583,586 B2Dana-Farber Cancer Institute, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders3 Jan 2023US 11,542,296 B2The Texas A&M University System
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Apr 2026US 2026/0116913 A1The Texas A&M University System
- Compounds and methods for the treatment of dermal and ocular disorders26 Feb 2026US 2026/0055110 A1Azura Ophthalmics Ltd.
- Compositions and methods for treating cns disorders7 Nov 2024US 2024/0368213 A1Sage Therapeutics, Inc.
- Neuroactive steroids and their methods of use18 Jul 2024US 2024/0239835 A9Sage Therapeutics, Inc.
- Neuroactive steroids and compositions thereof10 Aug 2023US 2023/0250129 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- 4-Aza-17.beta.-substituted-5.alpha.-androstan-3-one-reductase inhibitors159US 4,377,584 AMerck & Co., Inc. · 1983
- Androstane carbothioates130US 4,335,121 AGlaxo Group Limited · 1982
- Soft steroids having anti-inflammatory activity100US 4,996,335 A1991
- Methods to induce targeted protein degradation through bifunctional molecules71US 9,694,084 B2Dana-Farber Cancer Institute, Inc. · 2017
- Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series70US 5,232,917 AUniversity of Southern California · 1993